INOZYME PHARMA INC (INZY)
US45790W1080 - Common Stock
| TTM (2024-3-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -77.12M | -71.17M | -67.06M | -56.62M | -56.42M | |||
| Depreciation Amortization | 805.00K | 833.00K | 740.00K | 670.00K | 220.00K | |||
| Change In Working Capital | -2.30M | -3.08M | 2.01M | 90.00K | -110.00K | |||
| Other non cash items | 1.18M | 2.74M | 6.54M | 7.71M | 20.34M | |||
| OPERATING CASH FLOW | -77.44M | -70.67M | -57.76M | -48.15M | -35.97M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -150.00K | -298.00K | -410.00K | -400.00K | -570.00K | |||
| Other Investing Activity | -56.86M | -53.35M | -4.99M | 43.19M | -116.61M | |||
| INVESTING CASH FLOW | -57.02M | -53.65M | -5.40M | 42.80M | -117.18M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | 20.00M | 40.00M | 4.05M | N/A | N/A | |||
| Stock Issued/Repurchased | 86.03M | 85.97M | 68.74M | 610.00K | 149.81M | |||
| FINANCING CASH FLOW | 106.03M | 125.97M | 72.79M | 610.00K | 149.81M | |||
| Exchange Rate Effect | -28.00K | -18.00K | -30.00K | 20.00K | N/A | |||
| CHANGE IN CASH | -28.46M | 1.63M | 9.60M | -4.72M | -3.34M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -77.44M | -70.67M | -57.76M | -48.15M | -35.97M | |||
| Capital Expenditure | -150.00K | -298.00K | -410.00K | -400.00K | -570.00K | |||
| FREE CASH FLOW | -77.59M | -70.97M | -58.17M | -48.55M | -36.54M | |||
All data in USD